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Extensive Distortion and Dysfunction of an
Edwards Valeo Lifestent Placed for Stenosis
of the Superior Vena Cava
Ranjit Aiyagari,* MD, FACC, FSCAI
We present a case of multiple interventions to treat symptomatic stenosis of the supe-
rior vena cava in a child, with end-stage renal disease and a history of long-term
hemodialysis, who had required indwelling central venous catheters for several years.
The stenosis was successfully treated with an Edwards Valeo Lifestent, but recurrent
symptomatic superior vena caval stenosis developed within 5 months, requiring repeat
catheterization and stent placement. VC 2011 Wiley-Liss, Inc.
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INTRODUCTION
Stenosis of the superior vena cava (SVC) is an un-
usual condition in pediatric patients. When severe, it can
lead to symptomatic SVC syndrome, which includes
swelling of the face, neck, and arms, and it can poten-
tially lead to life-threatening dyspnea and dysphagia [1].
The most common risk factors for the development of
SVC stenosis in pediatric patients without congenital
heart disease include thoracic neoplasms (both malignant
and benign) and central venous catheterization with
associated scarring or thrombosis [2].
Endovascular stent therapy for SVC syndrome was
first described by Charnsangavej [3] and has become a
standard approach for therapy over the last two deca-
des. In a recent series of patients with SVC syndrome
and malignancy treated with a variety of different
stents, the technical success rate for stent placement
was 100%, with a procedural complication rate of
18%, and a 1-year restenosis rate of 12% [4].
We present a case of multiple interventions in a 9-
year-old child with end-stage renal disease who devel-
oped catheter-associated thrombosis and symptomatic,
high-grade SVC stenosis. Treatment with a Valeo Life-
stent (Edwards Lifesciences, Irvine, CA) resulted in a
suboptimal medium-term outcome and required semiur-
gent reintervention.
CASE REPORT
The patient was born prematurely at 32 weeks gesta-
tion with congenital renal dysplasia and chronic poly-
uric renal insufficiency. Peritoneal dialysis was insti-
tuted at age 8 months, but this approach was aban-
doned due to repeated episodes of peritonitis. To
institute hemodialysis, a 4.2-French Broviac catheter
(Bard, Salt Lake City, UT) was placed in the right sub-
clavian vein at age 20 months. This catheter malfunc-
tioned and was removed 11 days after placement. An
8-French PermCath catheter (Covidien, Mansfield,
MA) was placed in the right internal jugular vein at
age 29 months. Over the ensuing 10 months, the
patient developed multiple episodes of catheter mal-
function, and the right internal jugular venous catheters
were repeatedly replaced over a wire. When the patient
was 39 months old, the right internal jugular vein was
found to be occluded with drainage via collaterals. The
patient thereafter had multiple venous catheters placed
and replaced in the right subclavian vein. The patient
then underwent cadaveric renal transplantation at age
44 months.
Approximately 2 years after renal transplant, at age
5, the patient developed focal segmental glomeruloscle-
rosis. He was treated medically over the following 2
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years, but due to a need to resume hemodialysis, he
had a tunneled catheter placed in the left internal
jugular vein at age 7. This became infected and was
removed 5 months later, at which time an attempt
was made to reaccess the right internal jugular vein,
which was again found to be occluded. The patient
underwent construction of a left upper extremity
brachiobasilic arteriovenous fistula for continued
hemodialysis.
At age 9, the patient was noted to have mild signs
of SVC syndrome including facial edema. An echocar-
diogram showed probable thrombus within the SVC
with an estimated mean gradient of 20 mm Hg. There
was a small linear thrombus in the left innominate vein
without obstruction. A magnetic resonance venogram
was performed and showed long-segment SVC stenosis
for a length of 2.7 cm with a minimum diameter of 2–
3 mm; however, image quality was limited due to sus-
ceptibility artifact from a foreign body in the right
lower neck. A chest radiograph showed this to be a
2.5-cm-long fragment of a J-tipped wire near the area
of the mid right internal jugular vein.
Because of the new symptoms, the patient was taken
to the cardiac catheterization laboratory at age 9 years
6 months. Under general anesthesia, an 8-French
sheath was placed in the right femoral vein. Occlusion
of the right internal jugular vein was documented near
the site of the retained wire fragment. A 6-French
sheath was placed in the left internal jugular vein. The
mean pressure in the left innominate vein was 24 mm
Hg, while the right atrial mean pressure was 6 mm Hg.
Venography showed a complex, severe SVC stenosis
with multiple large venous collaterals draining the
upper body (Fig. 1). The minimum diameter of the
SVC was 3.0 mm and the stenotic segment was 3.0 cm
in length.
Fig. 1. Posteroanterior angiographic image showing diffuse, long-segment narrowing of the
superior vena cava (SVC) along its entire length. There is a dilated left innominate vein (LIV).
There is a large collateral (COLL) decompressing the LIV. The right atrium (RA) is seen below
the SVC.
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Balloon angioplasty was initially undertaken, with
multiple inflations of an 8 mm  3 cm Z-Med II bal-
loon (NuMed, Hopkinton, NY) to pressures of 10 atm,
resulting in a residual waist and no improvement in ste-
nosis. Therefore, the decision was made to place a stent.
A Valeo (Edwards Lifesciences, Irvine, CA) 10 mm 
36 mm premounted stent was chosen because of the
convenience of a premounted stent, the previously
reported high radial strength of this stent, and its ability
to be dilated in the future to 20 mm [5]. The stent was
deployed across the area of stenosis with balloon infla-
tion to 6 atm. Because there was some residual
narrowing of the upper part of the stent, the stent
was re-expanded with a single inflation to 12 atm of a
10 mm  3 cm Z-med II balloon (NuMed, Hopkinton,
NY), with no apparent waist on the balloon at maximal
inflation. Fluoroscopy showed mild residual stenosis in
the upper third of the stent with no obvious stent frac-
ture (Fig. 2), and angiography showed good flow
through the stent with no significant residual flow
through venous collaterals. Pressure measurement
showed a residual gradient of 4 mm Hg. The procedure
was concluded, and the patient was maintained on
Lovenox anticoagulation and followed clinically as an
outpatient.
In the first few months following stent placement,
the patient’s facial swelling markedly decreased. An
echocardiogram 5 weeks after stent placement
showed an estimated residual mean gradient of
4.5 mm Hg. However, 5 months after stent place-
ment, he again began to have periorbital edema.
Repeat echocardiogram at that time showed that the
mean estimated pressure gradient across the SVC
was again 17–21 mm Hg.
The patient, now age 9 years 11 months, was again
brought to the cardiac catheterization laboratory. Under
general anesthesia, access was again obtained in the
same locations with the same size sheaths, and the left
innominate vein mean pressure was measured at 23
mm Hg with a right atrial mean pressure of 7 mm Hg.
Fluoroscopy showed extensive stent distortion and dis-
ruption (Fig. 3A) and angiography showed recurrent
severe SVC stenosis with significant in-stent restenosis
(Fig. 3B). A 10 mm  36 mm iCAST stent (Atrium
Medical, Hudson, NH) was then placed over a 0.035-
in. Amplatz Super Stiff wire (Boston Scientific, Water-
town, MA) into the area of the existing fractured stent.
This was fully expanded with 8 atm of balloon pres-
sure. The new stent was then re-expanded with a 12
mm  4 cm Z-Med II balloon (NuMed, Hopkinton,
NY) inflated to 10 atm. There was no waist with this
inflation. Angiography showed significant improvement
(Fig. 4), and repeat pressure measurements showed a
residual gradient of 3 mm Hg.
The patient is free of symptoms of SVC syndrome 6
months after placement of the iCAST stent. An echo-
cardiogram performed 2 months after the final proce-
dure showed a residual estimated mean gradient of 5
mm Hg.
DISCUSSION
This patient is representative of many children who
are chronically dependent on central venous access,
whether for dialysis, medication administration, or
other purposes. Because of his high activity level,
potential for being less careful, and growth, the child
required multiple line exchanges and replacements.
Combined with the retained wire fragment and associ-
ated scar formation, this resulted in a clinically impor-
tant stenosis of the SVC.
SVC stenosis represents an ideal case for interven-
tion with intravascular stent placement. The relatively
straight course of the vessel and the ease of obtaining
access from above, below, or both facilitate recanaliza-
tion in the setting of total occlusion, as well as stent
placement with concomitant angiography.
The Valeo Lifestent is a premounted and open-cell
stainless steel triple helical stent that comes in diameters
ranging from 6 to 10 mm with lengths ranging from 18
to 56 mm. The larger (9–10 mm) diameter stents can be
Fig. 2. Posteroanterior fluoroscopic image showing a 10 mm
3 36 mm Edwards Valeo stent within the superior vena cava
(SVC) after implantation. The stent appears intact with mild
narrowing along its superior 1/3.
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delivered through 7-French sheaths, and overexpansion
to 18 mm diameters results not in foreshortening but
instead in larger gaps between the open cells [5].
This case illustrates that in the setting of vascular
stenosis with significant scar formation, the Valeo Life-
stent, even when not expanded above its nominal dia-
meter, may lack sufficient radial strength to achieve
lasting relief. This patient would likely have achieved
longer lasting relief of stenosis with use of a stent with
higher radial strength. This important limitation of the
Valeo Lifestent should be kept in mind.
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Fig. 4. Posteroanterior angiographic image showing good
patency of the superior vena cava after placement of a 10 mm
3 36 mm iCAST stent within the original stent and redilation
to 12 mm.
Fig. 3. (A) Posteroanterior fluoroscopic image showing the 10 mm 3 36 mm Edwards Valeo
stent within the superior vena cava 5 months after implantation. There is severe distortion
and deformation of the stent along its entire length. (B) Posteroanterior angiographic image
showing the distorted stent with recurrent, severe stenosis despite appropriate stent loca-
tion. There is also significant in-stent stenosis.
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